key: cord-0960866-uk2nmvih
authors: Alcindor, Magalie L.; Alcindor, FitzGerald; Richard, Kristy E.; Ajay, Geetha; Denis, Anne Marie; Dickson, Darlene M.; Lawal, Ekaete; Alcindor, Magaline A.; Allen, Deborah
title: COVID-19 Management In Pediatrics
date: 2021-03-09
journal: J Nurse Pract
DOI: 10.1016/j.nurpra.2021.02.010
sha: 3b7be200ab4a2aff5b92381f96df7bc89ac9fc12
doc_id: 960866
cord_uid: uk2nmvih

COVID-19 is a deadly global pandemic with scientific efforts improving our understanding of this novel coronavirus. No proven disease-specific therapies exist although various antiviral regimens offer some success. Many vaccines are in development and phase III clinical trial testing. COVID-19 thrives on medically fragile, elderly and socially disadvantaged, while children have been less affected. Children at risk are those with co-morbidities and neonates; the multisystem inflammatory syndrome is a severe version diagnosed in high-risk children. This article provides COVID-19 management for children, and implications for nursing and advanced practice providers. Suggested Reviewers: Response to Reviewers: As the review was a lot. Please see all of the revisions requested by the reviewers as an attachment in

Larger expelled droplets fall to the ground within seconds to minutes, while smaller ones remain circulating in the air 4 . Proximity and duration of exposure have been speculated to be greatest within 6 feet from the source and duration>15 minutes, however, prolonged durations at greater distances have resulted in positive transmissions. COVID-19 can survive on human skin for 9 hours and various surfaces (glass, polymer currency, stainless steel, vinyl and paper currency) for up to 28 days; 5 however, the virus loses potency once it leaves the host. Time of exposure to symptoms ranges from 5-11days 6 . Viral shedding can occur 2-3 days prior to symptom onset, therefore, asymptomatic and pre symptomatic individuals are considered infectious carriers. Asymptomatic transmission is important to guide screening and family education as the CDC and WHO recommend wearing masks, frequent hand washing/sanitizing, and social distancing of at least 6 feet to reduce transmission.

Infants 3 months old, presentations of fever, cough, myalgia and fatigue are common in viral infections and require testing: 7 influenza, parainfluenza, adenovirus, metapneumovirus, respiratory syncytial virus, and COVID-19 8 . Accurate COVID-19 screening requires real-time PCR (RT-PCR), IgG and IgM via ELISA or antigen test. The RT-PCR is the most commonly used and reliable test. The nasopharyngeal area, throat, or nares are usually swabbed but the virus can be detected in saliva, blood, urine, and stool 9 . The PCR value provides the viral RNA cycle threshold, or the number of viral replications needed to elicit a detectable signal 9 .The COVID-19 virus is detectable at Day 1 in the nasopharynx, peaks during the first week, and declines until undetectable over 3-6 weeks. A PCR<40 indicates clinical COVID-19 positivity 10 .

Lower PCR results equate to higher viral loads and sicker presentations. To illustrate, the PCR result for a severely ill patient will be much less than that of one who is asymptomatic. Reported values do not always reflect the clinical picture as viral load is not indicative of viral viability and a positive test still can J o u r n a l P r e -p r o o f be detected beyond the expected onset of symptoms 11 . Sampling from the buccal cavity have resulted in false-negative cases as lower viral loads were detected 12 , particularly in children with mild COVID-19 symptoms 13 .

COVID-19 antibody screening assesses antibody presence/absence after COVID-19 infection. This is primarily done upon the request of the parents. Serology detects IgG and IgM as early as the 4th day after exposure. While IgM is almost untraceable in the blood by 7 weeks after symptom onset, IgG may still be present 12 . Further, elevated cytokine levels have been reported in asymptomatic infants (n=6) born to symptomatic mothers diagnosed after delivery 13 . Longitudinal antibody testing found seroconversion, with two neonates positive for IgG with IgM antibodies. Contact tracing is initiated following a positive PCR test.

It was thought that vertical transmission of COVID-19 from mother to baby did not occur as evidenced by various birth cohorts 14 16 . The CDC recommends wearing a mask to minimize the viral load that can be inhaled; note that cloth masks are not recommended for children less than 2 years-old for fear of suffocation. Use of alcohol-based sanitizers for handwashing pose no threat to children who lick their hands after the hand sanitizer has fully dried. However, small amounts of liquid hand sanitizer can cause alcohol poisoning and hypoglycemia in children. Thus, children younger than 6 years old should be supervised when using alcohol-based sanitizer and it be J o u r n a l P r e -p r o o f should be kept out of the reach and sight. Hand sanitizers made of isopropyl alcohol may be more toxic than those made of ethanol.

Milder presentations in children has prompted exploration into pathophysiological differences from adult cases; Table 1 presents some observed differences 17 . One hypothesis for the differences in severity observed between pediatrics and adults related to cytokine release, 17, 18 ,as children may elicit a decreased response. Simply, by releasing less cytokines, less lung damage ensues 19 . There have been measured lower viral load responses in the respiratory tract of children once COVID-19 invades it (See Table 1 ). Another distinction is that the angiotensin converting enzyme-2, receptor (ACE-2) used by COVID-19 to enter cells is expressed differently in children and that pediatric lungs may have fewer or less mature ACE-2 receptors than adult counterparts 14, 19, 20 . Another factor lies in the endothelium of children's blood vessels is less susceptible to inflammation and clotting than adult endothelium which is prone to thrombosis resulting in myocardial infarctions and cerebral events 14, 21, 22 . Of note, COVID-19 presentations of entirely GI symptoms (nausea, vomiting, diarrhea, abdominal pain, and decreased appetite) occur primarily in adults. However, CT scanning reveals abnormalities consistent with those observed in COVID-19 pneumonia. It is postulated that the virus induces GI bacterial translocation to lung parenchyma, thereby causing increased capillary permeability and the observed CT pulmonary abnormalities 22 .

Thorough evaluation is vital when a child presents with mild GI or respiratory symptoms, with/without fever 8 . The differential diagnosis is broad and includes: other viruses, urinary tract infections, intraabdominal infections, viral and bacterial pneumonia, sepsis, and soft tissue infections, (See Table 2 ). Table 3 )

The majority of pediatric case presentations initially were milder and appeared to only be severe in those with comorbidities. However, the Multisystem Inflammatory Syndrome in Children (MIS-C) is a life-threatening complication, even after mild illness; further, those developing MIS-C often do not have pre-existing comorbidities 23, 24 . A child presenting with persistent fever > 24 hours, without obvious source or from possible coronavirus exposure, should be tested for COVID-19. Any pediatric demise in association with COVID-19 should be considered linked to MIS-C. 21, 22 Dry cough and fever are the most common symptoms in children aged 0-9 years. 22 Additional symptoms include: myalgia (15%), rhinorrhea (13%), nausea/vomiting (10%), abdominal pain (7%), diarrhea (14%), anosmia/ageusia (1%).

Symptoms for children aged 10-19 years include: fever (35%), cough (41%), dyspnea (16%), myalgia (30%), rhinorrhea (8%), diarrhea (14%), anosmia/ageusia (10%) 22 . Children <12 months old may present feeding difficulties and fever without a source. Abdominal pain, diarrhea, and vomiting are the most common gastrointestinal (GI) symptoms in children, but no GI bleeding has been reported.

Rashes are common in viral presentations; COVID-19 rashes are macular, papular (painful, purple or red), vesicular, and urticarial leading to the term 'COVID Toes' being coined for patients with reddishpurple nodules of the extremities 23 Table 5 ). Symptoms include fever, bilateral nonexudative conjunctivitis, lip/oral mucosa erythema (cracked red lips, strawberry tongue), rash, and cervical lymphadenopathy. Children who develop MIS-C tend to be older, sicker, and display greater elevations of inflammatory markers and more cardiac involvement. The CDC and WHO have developed MIS-C diagnostic criteria. 21, 24, 25 , (See Table 3 ). Children and adolescents with MIS-C typically present with prolonged fever of 4-6 days (100%), GI symptoms (abdominal pain, vomiting, diarrhea; 60-100%), rash (45-76%), conjunctivitis 30-81 %), mucous membrane involvement (27-76%), headache, lethargy (29-58%), tachypnea and dyspnea (21-65%), sore throat, myalgias, swollen feet/hands, and lymphadenopathy (6-16%). Clinically, they may present with an arrhythmia (12%), in shock (32-76%), respiratory failure (28-52%), acute renal failure or insufficiency (<52%), hepatitis/hepatomegaly (20%), or CNS dysfunction in 6-7% (encephalitis, seizures, coma, or meningoencephalitis). 25 As children with MIS-C tend to present with elevated markers of inflammation (CRP, ESR, D-dimer), they run the risk of coronary artery aneurysms. 26 The myriad signs and symptoms, along with hemodynamic compromise, that a child or adolescent presents with in the presence or upon suspicion of COVID-19

should alert the clinician to the possibility of MIS-C, Tables 3-5.

Studies Chest radiography is typically not required unless the child presents with fever, cough, abnormal pulmonary exam, or suspicion of pneumonia. Chest x-rays have exhibited limited sensitivity and specificity detecting pulmonary lesions in pediatric patients with mild COVID-19, therefore pulmonary CT scanning is a better diagnostic and monitoring tool. 13 Small nodular or speckled ground glass opacities are visualized on pulmonary CT, even in resolved cases with negative serology. 27

The majority of pediatric COVID-19 cases do not require laboratory testing aside from the rapid COVID-19 test or a PCR. Zhu and colleagues found 94% (n=157) patients with mild-moderate COVID-19

presentations had increased T-and B-cell lymphocytes and decreased neutrophils. 28 The neutrophil lymphocyte ratio was negatively associated with abnormal ALT, AST, CK-MB, and LDH results. However, Mussap reviewed 12 research studies reporting abnormal laboratory results, finding many inconsistencies in collection times, sampling methods, and tests utilized, resulting in a lack of homogeneity for laboratory interpretation 14 . Laboratory testing is, however, essential in the child presenting with signs and symptoms of MIS-C.

The best approach to detect MIS-C is to screen a very ill child or adolescent for the most common symptoms and perform a detailed physical exam. Being a multisystemic illness, diagnosis and treatment of MIS-C requires a multidisciplinary team involving infectious disease, rheumatology, cardiology, intensive care, and hematology. Imaging is selectively used based on presentation 26 . Echocardiography should be performed within 24 hours in the child with myocardial depression to rule out coronary aneurysms, mitral regurgitation or pericardial effusion; this is repeated within 24 hours and as-needed to follow illness progression. Chest radiography may be normal or may display pleural effusions, patchy consolidations, and atelectasis. Chest CT is performed for those with abnormal chest examination, chest

x-ray, or respiratory distress, and may demonstrate presence of nodular ground-glass opacification 13, 27 .

Severe gastrointestinal symptoms and abnormal abdominal examination may prompt an ultrasound or CT of the abdomen and pelvis; results may vary from non-specific findings to free fluid, ascites, bowel and mesenteric adenopathy/adenitis, or ileitis. In addition to labs monitored for severe illnesses, specific abnormalities include: hematologic abnormalities (lymphopenia, neutropenia, mild anemia, thrombocytopenia); elevated markers of inflammation (C-reactive protein, erythrocyte sedimentation rate, D-dimer, fibrinogen, procalcitonin, interleukin-6) 19, 25 .

COVID-19 can be prevented with hand hygiene, environmental decontamination, personal protective equipment (PPE), elimination of second-hand smoke, social distancing, and isolation of those infected 29.30-31 . Providers should teach caregivers that fever should be reported: either subjective fever (feeling feverish) or measured temperature > 100.4°F (38°C). 30 NPs should ensure use of reliable communication links and telehealth. Indications for immediate medical assistance include: children with poor oral intake; persistent fever; worsening dyspnea, especially at rest; and lethargy, especially in infants or children with co-morbidities. WHO guidelines for management of pediatric COVID-19 respiratory symptom management are summarized on (See Table 4 ).

Management of COVID-19 is generally supportive, yet may require progressive complex interventions ranging from oxygen therapy via nasal cannula to endotracheal intubation. Outpatient management is recommended for children with mild symptoms and stable vital signs; appropriate follow-up via telehealth or clinic encounter should occur within 48 hours for repeat laboratory and imaging testing for persistent or worsening symptoms. Hospitalization is required for children presenting with unstable vital signs, shock, respiratory distress and signs of cardiovascular dysfunction (coronary artery aneurysm, left ventricular depression, elevated troponins, brain natriuretic peptide (BNP), arrhythmia), MIS-C, and J o u r n a l P r e -p r o o f other end-organ dysfunction (altered mental status, seizures, dehydration, acute kidney injury, underlying immunodeficiency, cardiac or lung abnormalities). The inability to return for follow-up is an important consideration in the socially disadvantaged, such as a homeless child and can be used as a basis for admission 30 An alternative management strategy, Hyperbaric Oxygen Therapy (HBOT), is designed to increase blood oxygen levels. Severe COVID-19 revealed a decreased ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2:FiO2 ratio) with concomitant hypoxia and tachypnea. Low carbon dioxide levels were also observed, with the median partial pressure of carbon dioxide (PaCO2) level 34 J o u r n a l P r e -p r o o f mmHg. In HBOT, the patient is enclosed in the chamber, the pressure is raised, and 100% oxygen is administered. Administering 100% oxygen at ambient pressure increases oxygen delivery in blood 5fold, equating to 1.5 mL per deciliter. HBOT may provide a novel means of treating and/or mitigating respiratory conditions associated with COVID-19. In July 2020, the FDA approved expanded access to Remestemcel-L for MIS-C. It is an investigational allogeneic mesenchymal stem cell product taken from the bone marrow of an unrelated donor. It is administered via a series of intravenous infusions to candidates aged 2 months-17 years with severe MIS-C. The drug is an immunomodulator which interferes with the inflammatory process induced by the virus and stimulates the production of antiinflammatory cytokines at the affected tissues. Heparin is another potential regimen for asymptomatic patients 36 . Heparin has a very strong bonding to the same protein that coronavirus attaches to human cells, thereby competing for the receptor and precluding the sequelae of inflammation that contributes to morbidity and mortality. It is not known at this point how this research will apply to the pediatric population 36 . Glucocorticoids have decreased mortality in adults, but trials in children are on-going 37 

The growing prevalence of pediatric mental and behavioral health disorders coupled with scarce psychiatric resources have resulted in a substantial increase in the number of youths waiting in emergency departments and medical units for in-patient psychiatric care; 42 this has been exacerbated from the effects of lockdown and social distancing. As children and adolescents depend on friendships to maintain self-worth, manage anxiety and depression, the pandemic lockdown has increased feelings of isolation and depression among them despite their being adept at using social media platforms and gaming technology. A study on adolescents at the University of Amsterdam and Emma Children's Hospital, found a profound increase in severe anxiety, sleep problems during the country's lockdown J o u r n a l P r e -p r o o f and this problem was intensified when the children or the family knew personally someone who had COVID-19. Further, adolescents reported sadness, loneliness, isolation, inability to make friends and feeling abandoned, especially if they had to quarantine 43 . Since the pandemic, the National Alliance on Mental Illness has reported many young adults experiencing anxiety and depression attributed partly to social isolation. The group cautions for teachers and parents to look for warning signs, including severe risk-taking behavior, significant weight-loss, excessive use of drugs and alcohol and drastic mood swings.

The American Psychiatric Association Council on Children, Adolescents and their Families recommends that schools put in place a lesson plan to teach students on how to share their emotions; further, the National Alliance on Mental Illness emphasizes that "kids need to be kids." Pandemic challenges for health care providers (HCPs) to deliver mental health services to clients and their families at physical locations has prompted use of telehealth 44 . However, language and literacy barriers, limited access to internet technology, as well as socioeconomic disadvantages and limited income have negatively contributed toward mental health disparities that have arisen during the pandemic 45 . This pandemic has deeply affected families economically. Among low-income households, 93.5% report food insecurity, use of food pantries, economic instability, lack of health care access, and fear of contracting COVID-19 44 .

The US has observed significantly greater ratios of hospitalizations and deaths from COVID-19 in diverse racial and ethnic populations than non-Hispanic Whites 46 . Native Americans, African Americans, and Hispanics had hospitalization rates approximately five times that of non-Hispanic Whites 42 . Likewise, the pandemic has negatively affected the mental health of these diverse groups as businesses closed, social relationships changed, and jobs were lost 47 . Both African Americans and Hispanics (24%) recently reported higher rates of stress, anxiety, or emotional disturbances compared with non-Hispanic Whites (17%) in a cross-sectional, descriptive study (n =1,226) 47 . Nearly half of Hispanics (44%) and African Americans (42%) further reported work loss, reduced work hours, or cuts in income related to the COVID-19 crisis 47 . These factors could potentially play a role in United States health care disparities J o u r n a l P r e -p r o o f among diverse and vulnerable groups, particularly during a global pandemic. Telehealth, however, could fulfill the medical and psychiatric needs of Americans of all ethnic groups by increasing access to health care and controlling COVID-19 rates 45 .

Following recovery, the provider needs to assess the patient's infectivity as reinfection and reactivation may occur. Ye et al found five patients with previous COVID-19 infection presented with reactivation weeks later 42 . Post-infection immunity is an active topic that is fascinating the public and has boosted antibody testing, however, the clinical significance of the antibody response remains unclear. NPs can raise awareness and create public health campaigns to reduce the spread of this infection.

COVID-19 has serious health effects on pediatric patients. This review has focused on pediatric COVID-19 presentation and treatment as the long-term psychological and physical effects are yet to be known.

The last few months have shown that the pandemic does inflict psychological wounds on children and adolescents as well as on adults. Asymptomatic cases found in contact tracing weeks later present to clinic with vague lingering effects from the illness. Our knowledge has continued to grow and change as new case studies of variant symptom presentations, responses to treatment, vaccination responses and its immunity, and lingering or reactivated presentations are reported. It is incumbent upon nurse practitioners to stay abreast of evidence-based practices to prevent and mitigate COVID-19 and its mutations, while guiding the public in making safe decisions regarding schooling, sporting, and social activities that affect the participation of children. 

American Academy of Pediatrics and the Children's Hospital Association. Children and COVID-19: State Data Report. Summary of publicly reported data from 49 states

Children and COVID-19. State level data report as of 6/11/20

The effect of temperature on persistence of SARS-CoV-2 on common surfaces

Asymptomatic transmission of SARS-Co-V-2 and implications for gatherings. Influenza and other respiratory viruses

Clinical features of pediatric patients with COVID-19: a report of two-family cluster cases

From SARS to COVID-19: What we have learned about children infected with COVID-19

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV 2: An observational cohort study

Viral load dynamics and disease severity in patients infected with

SARS-CoV-2 in Zhejiang province, China

Interpreting diagnostic tests for SARS-CoV-2

Antibodies in infants born to mothers with covid-19 pneumonia

Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults

The importance of laboratory medicine in the era of COVID-19 pandemic: a 

J o u r n a l P r e -p r o o f